Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
@article{Rogers2012CosteffectivenessAO,
title={Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.},
author={J. G. Rogers and Robin R. Bostic and Kuo Bianchini Tong and Robert M. Adamson and Mark Russo and Mark S. Slaughter},
journal={Circulation. Heart failure},
year={2012},
volume={5 1},
pages={
10-6
}
}
BACKGROUND
Continuous-flow left ventricular assist devices (LVADs) have become the dominant devices for mechanical circulatory support, but their cost-effectiveness is undetermined. This study assessed the cost-effectiveness of continuous-flow devices for destination therapy versus optimal medical management in advanced heart failure and compared the results with previous estimates for pulsatile devices.
METHODS AND RESULTS
A Markov model was developed to assess cost-effectiveness. Survival… CONTINUE READING